This Advisory outlines how healthcare providers (i.e., obstetrician-gynecologists [OB-GYNs], primary care physicians, and other professionals who treat pregnant people) can take an active role in supporting the health of pregnant individuals who have OUD and their babies.

This document accompanies the Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. It offers information about child welfare systems and what the health care provider's role is in developing a Plan of Safe Care.

The fourth supplemental resource to SAMHSA’s Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants publication. This document contains information for pregnant people with a substance use disorder and preparing to deliver.

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.

This flyer is related to the public service announcement from SAMHSA's “Talk. They Hear You.” campaign encouraging parents to talk with their kids about opioids.

This wallet card is related to the public service announcement from SAMHSA's “Talk. They Hear You.” campaign encouraging military parents to talk with their kids about opioids.

This wallet card is related to the public service announcement from SAMHSA's “Talk. They Hear You.” campaign encouraging parents to talk with their kids about opioids.

This infographic is related to the public service announcement from SAMHSA's “Talk. They Hear You.” campaign for parents on the risks of opioids and why they should start talking with their kids about the facts.